0001213900-20-027391.txt : 20200918
0001213900-20-027391.hdr.sgml : 20200918
20200918170125
ACCESSION NUMBER: 0001213900-20-027391
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200916
FILED AS OF DATE: 20200918
DATE AS OF CHANGE: 20200918
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Linscott Walt Addison
CENTRAL INDEX KEY: 0001648585
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37521
FILM NUMBER: 201184561
MAIL ADDRESS:
STREET 1: 1860 MONTREAL ROAD
CITY: TUCKER
STATE: GA
ZIP: 30084
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intec Pharma Ltd.
CENTRAL INDEX KEY: 0001638381
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12 HARTOM STREET
STREET 2: HAR HOTZVIM
CITY: JERUSALEM
STATE: L3
ZIP: 777512
BUSINESS PHONE: 97225864657
MAIL ADDRESS:
STREET 1: 12 HARTOM STREET
STREET 2: HAR HOTZVIM
CITY: JERUSALEM
STATE: L3
ZIP: 777512
4
1
ownership.xml
X0306
4
2020-09-16
0
0001638381
Intec Pharma Ltd.
NTEC
0001648585
Linscott Walt Addison
C/O INTEC PHARMA LTD.
12 HARTOM STREET
JERUSALEM
L3
9777512
ISRAEL
0
1
0
0
Chief Business Officer
Stock Option (right to buy)
0.3215
2020-09-16
4
A
0
100000
0
A
2027-09-16
Ordinary Shares
100000
100000
D
The stock option vests and becomes exercisable in full on December 31, 2021.
/s/ Walt Linscott
2020-09-18